Pharmaceuticals & Therapeutics

Eli Lilly's strategic buyout of a Texas biotech isn't just a deal; it's a bet on a new scientific paradigm to solve the chronic pain crisis without opioids.

A construction firm is merging with an AI robotics leader to go public. The deal, backed by high-profile investors, is built on a new patent that could redefine autonomous warfare and create opportunities far beyond the battlefield.

Millions of adults are straightening their teeth, but not with braces. We examine the tech, economics, and human behavior driving the clear aligner boom.

The Shark Tank success story is betting on dessert-flavored rice cakes to capture a market that's grown 74%. Is this the future of guilt-free snacking?

The #1 natural dough brand is moving beyond cookies. Its push into breakfast is a calculated play to modernize a sleepy aisle and dominate the allergen-free space.

Adial Pharmaceuticals pivots from addiction to inflammation, securing $32M and poaching Azora's leadership to drive its new ulcerative colitis drug, AT177.

Arima Genomics' award-winning Aventa test is revolutionizing lymphoma diagnostics by seeing cancer in 3D, moving beyond 2D methods to find what others miss.

A new device aims to solve a problem created by our phones: sleepless nights. But is Sleenova's SoundMask a true digital detox or just more tech for the bedroom?

A US startup and a Japanese giant are betting on ammonia to power Japan's future. Their deal could become the blueprint for the global energy transition.

Quest's latest responsibility report claims leadership in ESG. We analyze its community investments, workforce strategy, and tech governance to gauge its impact.

A new partnership between Innoviva and Dr. Reddy's aims to bring a vital antibiotic, XACDURO®, to regions where a deadly hospital infection is rampant.

Hadron Energy's first patent for its Halo micro-reactor reveals a strategy of pragmatism, using proven tech to power data centers and remote towns.

LRM Aesthetics' new delivery system for its PDGF+ formula isn't just a product update; it’s a masterclass in how small innovations create major workflow gains.

The traditional roofing industry creates millions of tons of waste. A new bio-based solution is changing that, one roof at a time, saving money and the planet.

A biotech firm's non-hallucinogenic drug just passed a key safety test. Could this novel approach finally disrupt the challenging world of alcohol use disorder?

A new investment in clean alumina tech is more than a deal; it’s a strategic move to build a Western-controlled critical materials corridor in the Arctic.

A new pact between Canada’s CASTL and Ireland’s NIBRT, backed by top leaders, aims to solve a critical talent shortage and secure the global pharma supply chain.

Pluristyx secures a key Japanese patent for its rapid mRNA reprogramming tech, slashing iPSC production time and promising to unlock commercial-scale cell therapy.

A new surgical method called SMART, developed at Delray Medical Center, uses biological scaffolds to overcome the failure of sutures in critical muscle injuries.

Pharma giant MSD and health-tech innovator Nivi are using an AI chatbot to fight cervical cancer in Asia. Can this model overcome regulatory hurdles and scale?